Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Adrenal insufficiency | x | ||
| Agranulocytosis | x | ||
| Alveolitis allergic | x | ||
| Anaemia | x | ||
| Haemolytic anaemia | x | ||
| Anorexia | x | ||
| Dizziness | x | ||
| Drowsiness | x | ||
| Rash | x | ||
| Body temperature increased | x | ||
| Goitre | x | ||
| Headache | x | ||
| Hirsutism | x | ||
| Hypersensitivity | x | ||
| Hypotension | x | ||
| Hypothyroidism | x | ||
| Leukopenia | x | ||
| Nausea | x | ||
| Neutropenia | x | ||
| Pancytopenia | x | ||
| Pruritus | x | ||
| Precocious puberty | x | ||
| Tachycardia | x | ||
| Urticaria | x | ||
| Vascular resistance | x | ||
| Virilism | x | ||
| Vomiting | x | ||
| Myalgia | x | ||
| Hepatotoxicity | x | ||
| Haematocrit decreased | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |